Is Aquestive Therapeutics Inc (AQST) a Leader in the Drug Manufacturers

A rating of 96 puts Aquestive Therapeutics Inc (AQST) near the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. Aquestive Therapeutics Inc's score of 96 means it scores higher than 96% of stocks in the industry. Aquestive Therapeutics Inc also received an overall rating of 72, putting it above 72% of all stocks. Drug Manufacturers - Specialty & Generic is ranked 121 out of the 148 industries.

AQST has an Overall Score of 72. Find out what this means to you and get the rest of the rankings on AQST!

See Full AQST Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 72 would rank higher than 72 percent of all stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Aquestive Therapeutics Inc Stock Today?

Aquestive Therapeutics Inc (AQST) stock is trading at $2.08 as of 12:57 PM on Tuesday, Nov 28, a gain of $0.14, or 7.18% from the previous closing price of $1.94. The stock has traded between $1.96 and $2.14 so far today. Volume today is above average. So far 400,499 shares have traded compared to average volume of 224,025 shares. Click Here to get the full Stock Report for Aquestive Therapeutics Inc stock.